Revised Structure of Cercidinin A, a Novel Ellagitannin Having (R)-Hexahydroxydiphenoyl Esters at the 3, 4-Positions of Glucopyranose

The structue of cercidinin A, an ellagitannin isolated from the bark of Cercidiphyllum japonicum, was revised to 1, 2, 6-tri-O-galloyl-3, 4-(R)-hexahydroxydipenoyl-β-D-glucose by two-dimensional NMR spectral analysis. Cercidinin A represents the first ellagitannin possessing a hexahydroxydiphenoyl group at the 3, 4-positions of a modified 4C1-glucopyranose core

High-Pressure-Hydrogen-Induced Spin Reconfiguration in GdFe2 Observed by 57Fe-Polarized Synchrotron Radiation Mössbauer Spectroscopy with Nuclear Bragg Monochromator

57Fe-polarized synchrotron radiation Mössbauer spectroscopy (PSRMS) with an X-ray phase plate and a nuclear Bragg monochromator was used to study ferrimagnetic GdFe 2 in high-pressure hydrogen. The pressure-dependent spectraclearly showed a two-step magnetic transition of GdFe2. 57Fe-PSRMS with circular polarization gave direct evidence that the Fe moment was directed parallel to the net magnetization of the GdFe2 hydride at 20 GPa. This spin configuration was opposite to that of the initial GdFe2 , suggesting an extreme weakening of the antiferromagnetic interaction between Fe and Gd. 57Fe-PSRMS enables the characterization of the nonuniform properties of iron-based polycrystalline powder alloys. The excellent applicability of 57Fe-PSRMS covers a wide range of scientific fields

Contribution of Fetal Inflammatory Response Syndrome (FIRS) with or without Maternal-Fetal Inflammation in The Placenta to Increased Risk of Respiratory and Other Complications in Preterm Neonates

This study classifies fetal inflammatory response syndrome (FIRS) based on the presence or absence of maternal-fetal inflammation in the placenta and clarifies the association of FIRS with neonatal morbidities. Women (330) who delivered at gestational ages of 22w0d-33w6d were enrolled and grouped into four based on FIRS and maternal/fetal inflammatory response (MIR/FIR) statuses: Group A: without FIRS and MIR/FIR (reference group); Group B: MIR/FIR alone; Group C: FIRS and MIR/FIR; and Group D: FIRS without MIR/FIR. The associations between bronchopulmonary dysplasia (BPD), adverse neonatal outcomes, extremely low gestational age and Groups B, C, and D were investigated after adjustment for potential confounders. Among patients with FIRS, 29% were in Group D. The risk of BPD was increased in Groups C (adjusted odds ratio (aOR): 3.36; 95% confidence interval (CI): 1.14–9.89) and D (aOR: 4.17; 95% CI: 1.03–16.9), as was the risk of adverse neonatal outcomes (Group C: aOR: 7.17; 95% CI: 2.56–20.1; Group D: aOR: 6.84; 95% CI: 1.85–25.2). The risk of extremely low gestational age was increased in Group D (aOR: 3.85; 95% CI: 1.56–9.52). Therefore, FIRS without MIR/FIR is not rare and may be associated with neonatal morbidities more than FIRS and MIR/FIR

Pulmonary Langerhans Cell Histiocytosis That Progressed from a Single-system to a Multisystem Form despite Smoking Cessation

A 36-year-old Japanese man presented with cavities and nodular shadows in the lower lobes of his lungs and osteolytic lesions in the thoracic spine. He was diagnosed with multisystem Langerhans cell histiocytosis (LCH). Three years earlier, he had been noted to have small cavities and granular lesions noted in the upper lobes of his lungs, which later improved with smoking cessation. It was likely that his single-system pulmonary LCH (PLCH) progressed to multisystem LCH despite smoking cessation. Relapse or progression may occur in cases where PLCH lesions improve after smoking cessation. Thus, close follow-up is vital